Auditorium 2
Wed, 29.03.2023
18:15 - 19:45
Calendar Export
Share
Eisai, Inc - How the new treatment paradigm of advanced early-stage NSCLC impacts later lines
(ID 44)
Time
18:15 - 19:45
Chairs
Solange Peters
(Lausanne, Switzerland)
Location
Auditorium 2
Date
Wed, 29.03.2023
Eisai, Inc - How the new treatment paradigm of advanced early-stage NSCLC impacts later lines
(ID 44)
Industry Satellite Symposium
Calendar Export
Welcome and introduction
(ID 299)
Lecture Time
18:15 - 18:20
Speakers
Solange Peters
(Lausanne, Switzerland)
Session Name
Eisai, Inc - How the new treatment paradigm of advanced early-stage NSCLC impacts later lines
(ID 44)
Location
Auditorium 2, Bella Center, Copenhagen, Denmark
Date
Wed, 29.03.2023
Time
18:15 - 19:45
Eisai, Inc - How the new treatment paradigm of advanced early-stage NSCLC impacts later lines
(ID 44)
Industry Satellite Symposium
Calendar Export
Key considerations for the treatment of patients pre-treated with checkpoint inhibitors and chemotherapy
(ID 300)
Lecture Time
18:20 - 18:40
Speakers
Solange Peters
(Lausanne, Switzerland)
Session Name
Eisai, Inc - How the new treatment paradigm of advanced early-stage NSCLC impacts later lines
(ID 44)
Location
Auditorium 2, Bella Center, Copenhagen, Denmark
Date
Wed, 29.03.2023
Time
18:15 - 19:45
Eisai, Inc - How the new treatment paradigm of advanced early-stage NSCLC impacts later lines
(ID 44)
Industry Satellite Symposium
Calendar Export
Tumour microenvironment manipulations to improve patients outcomes: A translational review
(ID 301)
Lecture Time
18:40 - 19:00
Speakers
Fabrice Barlesi
(Villejuif, CEDEX 20, France)
Session Name
Eisai, Inc - How the new treatment paradigm of advanced early-stage NSCLC impacts later lines
(ID 44)
Location
Auditorium 2, Bella Center, Copenhagen, Denmark
Date
Wed, 29.03.2023
Time
18:15 - 19:45
Eisai, Inc - How the new treatment paradigm of advanced early-stage NSCLC impacts later lines
(ID 44)
Industry Satellite Symposium
Calendar Export
Debate on chemotherapy use in high PD-L1 expressors: The pros and cons
(ID 302)
Lecture Time
19:00 - 19:20
Speakers
Natasha Leighl
(Toronto, Canada)
Luis Paz-Ares
(Madrid, Spain)
Session Name
Eisai, Inc - How the new treatment paradigm of advanced early-stage NSCLC impacts later lines
(ID 44)
Location
Auditorium 2, Bella Center, Copenhagen, Denmark
Date
Wed, 29.03.2023
Time
18:15 - 19:45
Eisai, Inc - How the new treatment paradigm of advanced early-stage NSCLC impacts later lines
(ID 44)
Industry Satellite Symposium
Calendar Export
Expert panel discussion
(ID 303)
Lecture Time
19:20 - 19:40
Session Name
Eisai, Inc - How the new treatment paradigm of advanced early-stage NSCLC impacts later lines
(ID 44)
Location
Auditorium 2, Bella Center, Copenhagen, Denmark
Date
Wed, 29.03.2023
Time
18:15 - 19:45
Eisai, Inc - How the new treatment paradigm of advanced early-stage NSCLC impacts later lines
(ID 44)
Industry Satellite Symposium
Calendar Export
Conclusion
(ID 304)
Lecture Time
19:40 - 19:45
Speakers
Solange Peters
(Lausanne, Switzerland)
Session Name
Eisai, Inc - How the new treatment paradigm of advanced early-stage NSCLC impacts later lines
(ID 44)
Location
Auditorium 2, Bella Center, Copenhagen, Denmark
Date
Wed, 29.03.2023
Time
18:15 - 19:45